Company Description
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.
The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.
The company has a collaboration with the Department of Neurology’s Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies.
The company is based in Eden Prairie, Minnesota.
| Country | United States |
| Founded | 2009 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 18 |
| CEO | David Rosa |
Contact Details
Address: 7599 Anagram Drive Eden Prairie, Minnesota 55344 United States | |
| Phone | 952 426 1383 |
| Website | nmtc1.com |
Stock Details
| Ticker Symbol | NMTC |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 1500198 |
| CUSIP Number | 64130M308 |
| ISIN Number | US64130M3088 |
| Employer ID | 27-0863354 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| David A. Rosa M.D. | President, Chief Executive Officer and Director |
| Ronald W. McClurg | Chief Financial Officer |
| Christopher R. Volker CFA | Chief Operating Officer |
| Mark Christianson | Co-Founder, Business Development Director and Medical Sales Liaison |
| Steven Mertens | Chief Technology Officer |
| Emily Johns | Chief Administrative Officer and General Counsel |
| Hijaz Haris | Vice President of Marketing |
| Dr. Parag G. Patil M.D., Ph.D. | Chief Medical Advisor |
| David J. Wambeke | Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 12, 2026 | 424B5 | Filing |
| Jun 12, 2026 | 8-K | Current Report |
| Jun 12, 2026 | 10-Q/A | [Amend] Quarterly report |
| May 29, 2026 | SD | Form - SD |
| May 29, 2026 | SD | Form - SD |
| May 22, 2026 | 8-K | Current Report |
| May 12, 2026 | 10-Q | Quarterly Report |
| May 12, 2026 | 8-K | Current Report |
| May 4, 2026 | 8-K | Current Report |
| Apr 30, 2026 | 8-K | Current Report |